HEADER HYDROLASE/HYDROLASE INHIBITOR 26-MAY-06 2H5J TITLE CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-DMQD-CHO COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3, P17 SUBUNIT; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: RESIDUES 29-174; COMPND 5 SYNONYM: CASP-3; APOPAIN; CYSTEINE PROTEASE CPP32; YAMA PROTEIN; CPP- COMPND 6 32; SREBP CLEAVAGE ACTIVITY 1; SCA-1; COMPND 7 EC: 3.4.22.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-3, P12 SUBUNIT; COMPND 11 CHAIN: B, D; COMPND 12 FRAGMENT: RESIDUES 184-277; COMPND 13 EC: 3.4.22.-; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: AC-DMQD-CHO; COMPND 17 CHAIN: E, F; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET23B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CASP3, CPP32; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET23B; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES KEYWDS ENZYME CATALYSIS, CYSTEINE PROTEASE, APOPTOSIS, INDUCED FIT, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.FANG,P.I.BOROSS,J.TOZSER,I.T.WEBER REVDAT 5 15-NOV-23 2H5J 1 REMARK REVDAT 4 30-AUG-23 2H5J 1 SEQADV LINK REVDAT 3 13-JUL-11 2H5J 1 VERSN REVDAT 2 24-FEB-09 2H5J 1 VERSN REVDAT 1 19-SEP-06 2H5J 0 JRNL AUTH B.FANG,P.I.BOROSS,J.TOZSER,I.T.WEBER JRNL TITL STRUCTURAL AND KINETIC ANALYSIS OF CASPASE-3 REVEALS ROLE JRNL TITL 2 FOR S5 BINDING SITE IN SUBSTRATE RECOGNITION JRNL REF J.MOL.BIOL. V. 360 654 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16781734 JRNL DOI 10.1016/J.JMB.2006.05.041 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.206 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.202 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1992 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 39847 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.179 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.175 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1638 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 32408 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3874 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 460 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 4334.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 5 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 17426 REMARK 3 NUMBER OF RESTRAINTS : 15972 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 ANGLE DISTANCES (A) : 0.021 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.024 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.029 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.032 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.006 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.049 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2H5J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000037955. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : SI 220 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, MADCCD REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40221 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.24500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1CP3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE, 5% GLYCEROL, 10 REMARK 280 MM DITHIOTHREITOL AND 14-18% PEG 6000, PH 6.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.67000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -88.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE INHIBITOR IS COVALENTLY CONNECTED TO CYS OF THE ENZYME TO FORM REMARK 400 A HEMITHIOKETAL REMARK 400 REMARK 400 THE CASPASE-7 INHIBITOR AC-DMQD-CHO IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CASPASE-7 INHIBITOR AC-DMQD-CHO REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 ILE A 31 REMARK 465 SER A 32 REMARK 465 LEU A 33 REMARK 465 SER C 29 REMARK 465 GLY C 30 REMARK 465 ILE C 31 REMARK 465 SER C 32 REMARK 465 LEU C 33 REMARK 465 ASP C 34 REMARK 465 CYS D 184 REMARK 465 HIS D 278 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 58 C - N - CA ANGL. DEV. = 15.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 58 15.22 -49.78 REMARK 500 LYS B 229 -26.49 -162.67 REMARK 500 PHE B 275 32.23 -84.34 REMARK 500 LYS C 82 30.84 78.61 REMARK 500 GLU C 106 -179.65 -68.68 REMARK 500 SER C 120 -174.23 -175.06 REMARK 500 ALA C 162 154.41 174.27 REMARK 500 LYS D 229 -40.78 -131.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF AC-DMQD-CHO REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF AC-DMQD-CHO REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2H5I RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH AC-DEVD-CHO REMARK 900 RELATED ID: 2H65 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH AC-VDVAD-CHO DBREF 2H5J A 29 174 UNP P42574 CASP3_HUMAN 29 174 DBREF 2H5J C 29 174 UNP P42574 CASP3_HUMAN 29 174 DBREF 2H5J B 184 277 UNP P42574 CASP3_HUMAN 184 277 DBREF 2H5J D 184 277 UNP P42574 CASP3_HUMAN 184 277 DBREF 2H5J E 1 5 PDB 2H5J 2H5J 1 5 DBREF 2H5J F 1 5 PDB 2H5J 2H5J 1 5 SEQADV 2H5J HIS B 278 UNP P42574 EXPRESSION TAG SEQADV 2H5J HIS D 278 UNP P42574 EXPRESSION TAG SEQRES 1 A 146 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 146 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 146 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 146 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 146 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 146 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 146 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 146 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 146 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 146 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 146 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 A 146 ILE GLU THR SEQRES 1 B 95 CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR ALA SEQRES 2 B 95 TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SER SEQRES 3 B 95 LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA MET SEQRES 4 B 95 LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS ILE SEQRES 5 B 95 LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE GLU SEQRES 6 B 95 SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS GLN SEQRES 7 B 95 ILE PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU TYR SEQRES 8 B 95 PHE TYR HIS HIS SEQRES 1 C 146 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 C 146 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 C 146 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 C 146 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 C 146 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 C 146 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 C 146 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 C 146 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 C 146 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 C 146 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 C 146 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 C 146 ILE GLU THR SEQRES 1 D 95 CYS HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR ALA SEQRES 2 D 95 TYR SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SER SEQRES 3 D 95 LYS ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA MET SEQRES 4 D 95 LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS ILE SEQRES 5 D 95 LEU THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE GLU SEQRES 6 D 95 SER PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS GLN SEQRES 7 D 95 ILE PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU TYR SEQRES 8 D 95 PHE TYR HIS HIS SEQRES 1 E 5 ACE ASP MET GLN ASJ SEQRES 1 F 5 ACE ASP MET GLN ASJ HET ACE E 1 3 HET ASJ E 5 8 HET ACE F 1 3 HET ASJ F 5 8 HETNAM ACE ACETYL GROUP HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID FORMUL 5 ACE 2(C2 H4 O) FORMUL 5 ASJ 2(C4 H9 N O3) FORMUL 7 HOH *460(H2 O) HELIX 1 1 HIS A 56 GLY A 60 5 5 HELIX 2 2 GLY A 66 LEU A 81 1 16 HELIX 3 3 THR A 92 LYS A 105 1 14 HELIX 4 4 LEU A 136 PHE A 142 1 7 HELIX 5 5 CYS A 148 THR A 152 5 5 HELIX 6 6 TRP B 214 ALA B 227 1 14 HELIX 7 7 GLU B 231 PHE B 247 1 17 HELIX 8 8 ASP B 253 HIS B 257 5 5 HELIX 9 9 HIS C 56 GLY C 60 5 5 HELIX 10 10 GLY C 66 LEU C 81 1 16 HELIX 11 11 THR C 92 GLU C 106 1 15 HELIX 12 12 LEU C 136 PHE C 142 1 7 HELIX 13 13 CYS C 148 THR C 152 5 5 HELIX 14 14 TRP D 214 ALA D 227 1 14 HELIX 15 15 GLU D 231 PHE D 247 1 17 HELIX 16 16 ASP D 253 HIS D 257 5 5 SHEET 1 A12 GLU A 84 ASN A 89 0 SHEET 2 A12 GLU A 43 ASN A 51 1 N ILE A 49 O LYS A 88 SHEET 3 A12 ARG A 111 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 A12 LYS A 156 GLN A 161 1 O LEU A 157 N PHE A 114 SHEET 5 A12 PHE B 193 TYR B 197 1 O ALA B 196 N PHE A 158 SHEET 6 A12 CYS B 264 SER B 267 -1 O VAL B 266 N TYR B 195 SHEET 7 A12 CYS D 264 SER D 267 -1 O SER D 267 N ILE B 265 SHEET 8 A12 PHE D 193 TYR D 197 -1 N TYR D 195 O VAL D 266 SHEET 9 A12 LYS C 156 GLN C 161 1 N PHE C 158 O ALA D 196 SHEET 10 A12 ARG C 111 LEU C 119 1 N PHE C 114 O LEU C 157 SHEET 11 A12 GLU C 43 ASN C 51 1 N ILE C 48 O VAL C 117 SHEET 12 A12 GLU C 84 ASN C 89 1 O LYS C 88 N ILE C 49 SHEET 1 B 3 GLY A 122 GLU A 123 0 SHEET 2 B 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 B 3 GLY A 132 ASP A 135 -1 O GLY A 132 N GLY A 129 SHEET 1 C 2 ILE A 172 GLU A 173 0 SHEET 2 C 2 LYS D 186 ILE D 187 -1 O ILE D 187 N ILE A 172 SHEET 1 D 2 LYS B 186 ILE B 187 0 SHEET 2 D 2 ILE C 172 GLU C 173 -1 O ILE C 172 N ILE B 187 SHEET 1 E 3 GLY B 212 SER B 213 0 SHEET 2 E 3 TRP B 206 ASN B 208 -1 N ASN B 208 O GLY B 212 SHEET 3 E 3 MET E 3 GLN E 4 -1 O MET E 3 N ARG B 207 SHEET 1 F 3 GLY C 122 GLU C 123 0 SHEET 2 F 3 ILE C 126 GLY C 129 -1 O ILE C 126 N GLU C 123 SHEET 3 F 3 GLY C 132 ASP C 135 -1 O GLY C 132 N GLY C 129 SHEET 1 G 3 GLY D 212 SER D 213 0 SHEET 2 G 3 TRP D 206 ASN D 208 -1 N ASN D 208 O GLY D 212 SHEET 3 G 3 MET F 3 GLN F 4 -1 O MET F 3 N ARG D 207 LINK SG CYS A 163 C ASJ E 5 1555 1555 1.79 LINK SG CYS C 163 C ASJ F 5 1555 1555 1.80 LINK C ACE E 1 N ASP E 2 1555 1555 1.32 LINK C GLN E 4 N ASJ E 5 1555 1555 1.32 LINK C ACE F 1 N ASP F 2 1555 1555 1.33 LINK C GLN F 4 N ASJ F 5 1555 1555 1.33 SITE 1 AC1 20 ARG A 64 HIS A 121 GLY A 122 GLN A 161 SITE 2 AC1 20 CYS A 163 TYR B 204 SER B 205 TRP B 206 SITE 3 AC1 20 ARG B 207 ASN B 208 SER B 209 TRP B 214 SITE 4 AC1 20 SER B 249 PHE B 250 PHE B 256 HOH B 488 SITE 5 AC1 20 HOH E 365 HOH E 507 HOH E 539 HOH E 744 SITE 1 AC2 23 ARG C 64 HIS C 121 GLY C 122 GLN C 161 SITE 2 AC2 23 CYS C 163 HOH C 720 TYR D 204 SER D 205 SITE 3 AC2 23 TRP D 206 ARG D 207 ASN D 208 SER D 209 SITE 4 AC2 23 TRP D 214 SER D 249 PHE D 250 PHE D 256 SITE 5 AC2 23 HOH D 405 HOH D 547 HOH F 448 HOH F 546 SITE 6 AC2 23 HOH F 621 HOH F 630 HOH F 649 CRYST1 50.150 69.340 94.090 90.00 102.37 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019940 0.000000 0.004373 0.00000 SCALE2 0.000000 0.014422 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010881 0.00000